The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Vascular Responses to Drug Eluting Stents: Importance of Delayed Healing
Open accessAbstract
Polymer-based sirolimus- (Cypher) and paclitaxel-eluting (Taxus) drug eluting stents have become the treatment of choice for patients with symptomatic coronary artery disease undergoing percutaneous coronary intervention (PCI). Although these stents reduce rates of restenosis compared with bare metal stents (BMS), late thrombosis, a life threatening complication, has emerged as a major safety concern. Our understanding of the pathophysiology of late DES thrombosis is derived from animal and human pathologic samples taken after implantation of these devices. These data indicate that both DES cause substantial impairment in arterial healing characterized by lack of complete reendothelialization and persistence of fibrin when compared with BMS. This delayed healing is the primary substrate underlying all cases of late DES thrombosis at autopsy. Several additional risk factors for late stent thrombosis such as penetration of necrotic core, malapposition, overlapping stent placement, excessive stent length, and bifurcation lesions represent additional barriers to healing and should be avoided if DES are to be used to minimize the risk of late thrombosis. Because the time course of complete healing with DES in man is unknown, the optimal duration of antiplatelet treatment remains to be determined.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moses, J. W., Leon, M. B., Popma, J. J., Fitzgerald, P. J., Holmes, D. R., O'Shaughnessy, C., Caputo, R. P., Kereiakes, D. J., Williams, D. O., Teirstein, P. S., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035071 · Cited by 4,224
Iakovou, I. (2005) · JAMA · doi:10.1001/jama.293.17.2126 · Cited by 3,132
A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease
Stone, G. W., Ellis, S. G., Cox, D. A., Hermiller, J., O'Shaughnessy, C., Mann, J. T., Turco, M., Caputo, R., Bergin, P., Greenberg, J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032441 · Cited by 2,749
Pathology of Drug-Eluting Stents in Humans
Joner, M., Finn, A. V., Farb, A., Mont, E. K., Kolodgie, F. D., Ladich, E., Kutys, R., Skorija, K., Gold, H. K., & Virmani, R. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.03.042 · Cited by 2,744
Self-citationDaemen, J., Wenaweser, P., Tsuchida, K., Abrecht, L., Vaina, S., Morger, C., Kukreja, N., Jüni, P., Sianos, G., Hellige, G., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60314-6 · Cited by 1,757
Safety and Efficacy of Sirolimus- and Paclitaxel-Eluting Coronary Stents
Stone, G. W., Moses, J. W., Ellis, S. G., Schofer, J., Dawkins, K. D., Morice, M.-C., Colombo, A., Schampaert, E., Grube, E., Kirtane, A. J., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067193 · Cited by 1,631
Virmani, R., Guagliumi, G., Farb, A., Musumeci, G., Grieco, N., Motta, T., Mihalcsik, L., Tespili, M., Valsecchi, O., & Kolodgie, F. D. (2004) · Circulation · doi:10.1161/01.cir.0000116202.41966.d4 · Cited by 1,469
Self-citationStent Thrombosis in Randomized Clinical Trials of Drug-Eluting Stents
Mauri, L., Hsieh, W.-H., Massaro, J. M., Ho, K. K. L., D'Agostino, R., & Cutlip, D. E. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067731 · Cited by 1,441
Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy
McFadden, E. P., Stabile, E., Regar, E., Cheneau, E., Ong, A. T., Kinnaird, T., Suddath, W. O., Weissman, N. J., Torguson, R., Kent, K. M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17275-9 · Cited by 1,436
Late Clinical Events After Clopidogrel Discontinuation May Limit the Benefit of Drug-Eluting Stents
Pfisterer, M., Brunner-La Rocca, H. P., Buser, P. T., Rickenbacher, P., Hunziker, P., Mueller, C., Jeger, R., Bader, F., Osswald, S., & Kaiser, C. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.10.026 · Cited by 1,303
Finn, A. V., Joner, M., Nakazawa, G., Kolodgie, F., Newell, J., John, M. C., Gold, H. K., & Virmani, R. (2007) · Circulation · doi:10.1161/circulationaha.107.693739 · Cited by 1,277
Self-citationLong-Term Outcomes with Drug-Eluting Stents versus Bare-Metal Stents in Sweden
Lagerqvist, B., James, S. K., Stenestrand, U., Lindbäck, J., Nilsson, T., & Wallentin, L. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067722 · Cited by 1,197
Grines, C. L., Bonow, R. O., Casey, D. E., Gardner, T. J., Lockhart, P. B., Moliterno, D. J., O’Gara, P., & Whitlow, P. (2007) · Circulation · doi:10.1161/circulationaha.106.180944 · Cited by 1,140
Analysis of 14 Trials Comparing Sirolimus-Eluting Stents with Bare-Metal Stents
Kastrati, A., Mehilli, J., Pache, J., Kaiser, C., Valgimigli, M., Kelbæk, H., Menichelli, M., Sabaté, M., Suttorp, M. J., Baumgart, D., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067484 · Cited by 1,006
Drug-Eluting Stent and Coronary Thrombosis: Biological Mechanisms and Clinical Implications
Lüscher, T. F., Steffel, J., Eberli, F. R., Joner, M., Nakazawa, G., Tanner, F. C., & Virmani, R. (2007) · Circulation · doi:10.1161/circulationaha.106.675934 · Cited by 906
Self-citationGuha, M., & Mackman, N. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203298200 · Cited by 799
Axel, D. I., Kunert, W., Göggelmann, C., Oberhoff, M., Herdeg, C., Küttner, A., Wild, D. H., Brehm, B. R., Riessen, R., Köveker, G., et al. (1997) · Circulation · doi:10.1161/01.cir.96.2.636 · Cited by 784
Stent-Based Delivery of Sirolimus Reduces Neointimal Formation in a Porcine Coronary Model
Suzuki, T., Kopia, G., Hayashi, S.-I., Bailey, L. R., Llanos, G., Wilensky, R., Klugherz, B. D., Papandreou, G., Narayan, P., Leon, M. B., et al. (2001) · Circulation · doi:10.1161/hc3601.093987 · Cited by 708
A Pooled Analysis of Data Comparing Sirolimus-Eluting Stents with Bare-Metal Stents
Spaulding, C., Daemen, J., Boersma, E., Cutlip, D. E., & Serruys, P. W. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066633 · Cited by 704
Kuchulakanti, P. K., Chu, W. W., Torguson, R., Ohlmann, P., Rha, S.-W., Clavijo, L. C., Kim, S.-W., Bui, A., Gevorkian, N., Xue, Z., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.600155 · Cited by 639
Morphological Predictors of Restenosis After Coronary Stenting in Humans
Farb, A., Weber, D. K., Kolodgie, F. D., Burke, A. P., & Virmani, R. (2002) · Circulation · doi:10.1161/01.cir.0000019071.72887.bd · Cited by 593
Self-citationSirolimus-Eluting versus Uncoated Stents in Acute Myocardial Infarction
Spaulding, C., Henry, P., Teiger, E., Beatt, K., Bramucci, E., Carrié, D., Slama, M. S., Merkely, B., Erglis, A., Margheri, M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062006 · Cited by 564
Finn, A. V., Kolodgie, F. D., Harnek, J., Guerrero, L. J., Acampado, E., Tefera, K., Skorija, K., Weber, D. K., Gold, H. K., & Virmani, R. (2005) · Circulation · doi:10.1161/circulationaha.104.508937 · Cited by 556
Self-citationPathological Mechanisms of Fatal Late Coronary Stent Thrombosis in Humans
Farb, A., Burke, A. P., Kolodgie, F. D., & Virmani, R. (2003) · Circulation · doi:10.1161/01.cir.0000091115.05480.b0 · Cited by 478
Self-citationTissue Factor in Cardiovascular Diseases: Molecular Mechanisms and Clinical Implications
Steffel, J., Lüscher, T. F., & Tanner, F. C. (2006) · Circulation · doi:10.1161/circulationaha.105.567297 · Cited by 456
Paclitaxel-Eluting versus Uncoated Stents in Primary Percutaneous Coronary Intervention
Laarman, G. J., Suttorp, M. J., Dirksen, M. T., van Heerebeek, L., Kiemeneij, F., Slagboom, T., van der Wieken, L. R., Tijssen, J. G. P., Rensing, B. J., & Patterson, M. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062598 · Cited by 437
Heldman, A. W., Cheng, L., Jenkins, G. M., Heller, P. F., Kim, D.-W., Ware, M., Nater, C., Hruban, R. H., Rezai, B., Abella, B. S., et al. (2001) · Circulation · doi:10.1161/01.cir.103.18.2289 · Cited by 435
Pathological Analysis of Local Delivery of Paclitaxel Via a Polymer-Coated Stent
Farb, A., Heller, P. F., Shroff, S., Cheng, L., Kolodgie, F. D., Carter, A. J., Scott, D. S., Froehlich, J., & Virmani, R. (2001) · Circulation · doi:10.1161/hc3001.092037 · Cited by 423
Self-citationGrewe, P. H., Deneke, T., Machraoui, A., Barmeyer, J., & Müller, K.-M. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00486-6 · Cited by 401
Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation
Hofma, S. H., van der Giessen, W. J., van Dalen, B. M., Lemos, P. A., McFadden, E. P., Sianos, G., Ligthart, J. M. R., van Essen, D., de Feyter, P. J., & Serruys, P. W. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi571 · Cited by 384
Taxanes: Microtubule and Centrosome Targets, and Cell Cycle Dependent Mechanisms of Action
Abal, M., Andreu, J., & Barasoain, I. (2003) · Current Cancer Drug Targets · doi:10.2174/1568009033481967 · Cited by 383
Sirolimus-Eluting Stents Associated With Paradoxic Coronary Vasoconstriction
Togni, M., Windecker, S., Cocchia, R., Wenaweser, P., Cook, S., Billinger, M., Meier, B., & Hess, O. M. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.062 · Cited by 373
Drug eluting stents: are human and animal studies comparable?
Virmani, R., Kolodgie, F. D., Farb, A., & Lafont, A. (2003) · Heart · doi:10.1136/heart.89.2.133 · Cited by 300
Self-citationDrachman, D. E., Edelman, E. R., Seifert, P., Groothuis, A. R., Bornstein, D. A., Kamath, K. R., Palasis, M., Yang, D., Nott, S. H., & Rogers, C. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01020-2 · Cited by 286
CARTER, A. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.04.029 · Cited by 281
Tanner, F. C., Boehm, M., Akyürek, L. M., San, H., Yang, Z.-Y., Tashiro, J., Nabel, G. J., & Nabel, E. G. (2000) · Circulation · doi:10.1161/01.cir.101.17.2022 · Cited by 229
Balakrishnan, B., Tzafriri, A. R., Seifert, P., Groothuis, A., Rogers, C., & Edelman, E. R. (2005) · Circulation · doi:10.1161/circulationaha.104.512475 · Cited by 210
Extracellular Matrix Changes in Stented Human Coronary Arteries
Farb, A., Kolodgie, F. D., Hwang, J.-Y., Burke, A. P., Tefera, K., Weber, D. K., Wight, T. N., & Virmani, R. (2004) · Circulation · doi:10.1161/01.cir.0000139337.56084.30 · Cited by 203
Self-citationRole for p27 Kip1 in Vascular Smooth Muscle Cell Migration
Sun, J., Marx, S. O., Chen, H.-J., Poon, M., Marks, A. R., & Rabbani, L. E. (2001) · Circulation · doi:10.1161/01.cir.103.24.2967 · Cited by 179
Viñals, F., Chambard, J. C., & Pouysségur, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.38.26776 · Cited by 165
Steffel, J., Latini, R. A., Akhmedov, A., Zimmermann, D., Zimmerling, P., Lüscher, T. F., & Tanner, F. C. (2005) · Circulation · doi:10.1161/circulationaha.105.569129 · Cited by 158
Kolodgie, F. D., John, M. C., Khurana, C. S., Farb, A. A., Wilson, P. S., Acampado, E., Desai, N. P., Soon‐Shiong, P., & Virmani, R. (2002) · Circulation · doi:10.1161/01.cir.0000032141.31476.15 · Cited by 129
Self-citationParry, T. J., Brosius, R., Thyagarajan, R., Carter, D., Argentieri, D. C., Falotico, R., & Siekierka, J. J. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.09.042 · Cited by 129
Potent Inhibitory Effect of Sirolimus on Circulating Vascular Progenitor Cells
Fukuda, D., Sata, M., Tanaka, K., & Nagai, R. (2005) · Circulation · doi:10.1161/01.cir.0000155612.47040.17 · Cited by 127
Stähli, B. E., Camici, G. G., Steffel, J., Akhmedov, A., Shojaati, K., Graber, M., Lüscher, T. F., & Tanner, F. C. (2006) · Circulation Research · doi:10.1161/01.res.0000233379.92010.fd · Cited by 115
Effects of Oral Prednisone After Stenting in a Rabbit Model of Established Atherosclerosis
Ribichini, F. L., Joner, M., Ferrero, V., Finn, A. V., Crimins, J., Nakazawa, G., Acampado, E., Kolodgie, F. D., Vassanelli, C., & Virmani, R. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.03.031 · Cited by 72
Self-citationMuldowney, J. A. S., Stringham, J. R., Levy, S., Gleaves, L. A., Eren, M., Piana, R. N., & Vaughan, D. E. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000254677.12861.b8 · Cited by 62
Cited by
Chiu, J.-J., & Chien, S. (2011) · Physiological Reviews · doi:10.1152/physrev.00047.2009 · Cited by 2,280
Endothelial Cell Recovery Between Comparator Polymer-Based Drug-Eluting Stents
Joner, M., Nakazawa, G., Finn, A. V., Quee, S. C., Coleman, L., Acampado, E., Wilson, P. S., Skorija, K., Cheng, Q., Xu, X., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.04.030 · Cited by 641
Self-citationNakazawa, G., Finn, A. V., Joner, M., Ladich, E., Kutys, R., Mont, E. K., Gold, H. K., Burke, A. P., Kolodgie, F. D., & Virmani, R. (2008) · Circulation · doi:10.1161/circulationaha.107.762047 · Cited by 611
Self-citationByrne, R. A., Joner, M., & Kastrati, A. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv511 · Cited by 609
Self-citationVascular Inflammation and Repair
Inoue, T., Croce, K., Morooka, T., Sakuma, M., Node, K., & Simon, D. I. (2011) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2011.05.025 · Cited by 480
Metadata
- Authors
- Finn, A. V., Nakazawa, G., Joner, M., Kolodgie, F. D., Mont, E. K., Gold, H. K., & Virmani, R.
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 2007-07
- Volume
- 27
- Issue
- 7
- Pages
- 1500-1510
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2119470649
- Cited by
- 900
- References
- 47
- FWCI
- 57.79
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.